We are live on ! Find out more
DFO

Duquesne Family Office Portfolio holdings

AUM $3.38B
1-Year Est. Return 61.92%
This Fund
S&P 500
This Quarter Est. Return
+17.83%
1 Year Est. Return
+61.92%
3 Year Est. Return
+280.57%
5 Year Est. Return
+393.65%
10 Year Est. Return
+4,147.23%
AUM
$1.02B
AUM Growth
+$205M
Cap. Flow
+$115M
Cap. Flow %
11.29%
Top 10 Hldgs %
55.35%
Holding
52
New
16
Increased
14
Reduced
3
Closed
17

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$82.7M
2
HDB icon
HDFC Bank
HDB
+$35.2M
3
META icon
Meta Platforms (Facebook)
META
+$32.9M
4
TGT icon
Target
TGT
+$30.3M
5
HD icon
Home Depot
HD
+$29.8M

Sector Composition

Rank Sector Weight
1 Healthcare 29.96%
2 Consumer Discretionary 26.86%
3 Financials 12.47%
4 Consumer Staples 9.62%
5 Technology 6.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
M icon
26
Macy's
M
$6.8B
$16.5M 1.61%
250,200
+3,800
+2% +$230K
KSS icon
27
Kohl's
KSS
$2.29B
$14M 1.38%
229,900
-94,000
-29% -$5.43M
FL
28
DELISTED
Foot Locker
FL
$11.8M 1.16%
210,400
+35,000
+20% +$1.94M
LUV icon
29
Southwest Airlines
LUV
$22.8B
$11.4M 1.12%
+270,000
New +$10.1M
MFRM
30
DELISTED
MATTRESS FIRM HLDG CORP COM STK (DE)
MFRM
$10.2M 1%
+176,200
New +$11M
NKTR icon
31
Nektar Therapeutics
NKTR
$2.33B
$10.2M 1%
+43,667
New +$9.33M
CCI icon
32
Crown Castle
CCI
$34.2B
$9.37M 0.92%
+119,000
New +$9.54M
YPF icon
33
YPF
YPF
$204B
$7.91M 0.78%
298,900
JUNO
34
DELISTED
Juno Therapeutics, Inc.
JUNO
$3.65M 0.36%
+70,000
New +$3.13M
VA
35
DELISTED
Virgin America Inc.
VA
$350K 0.03%
+8,100
New +$292K
AMGN icon
36
Amgen
AMGN
$205B
-158,900
Closed -$22.3M
CCJ icon
37
Cameco
CCJ
$38.9B
-1,428,200
Closed -$25.2M
DIA icon
38
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.6B
-58,300
Closed -$9.91M
GDX icon
39
VanEck Gold Miners ETF
GDX
$23B
-1,546,600
Closed -$33M
GILD icon
40
Gilead Sciences
GILD
$161B
-217,500
Closed -$23.2M
GOOG icon
41
Alphabet (Google) Class C
GOOG
$4.58T
-3,345,360
Closed -$98.2M
MRK icon
42
Merck
MRK
$315B
-345,421
Closed -$19.5M
SCHW
43
Charles Schwab
SCHW
$184B
-485,700
Closed -$14.3M
VRTX icon
44
Vertex Pharmaceuticals
VRTX
$120B
-146,600
Closed -$16.5M
WBA
45
DELISTED
Walgreens Boots Alliance
WBA
-648,000
Closed -$38.4M
XLF icon
46
State Street Financial Select Sector SPDR ETF
XLF
$57.8B
-488,352
Closed -$9.93M
XLV icon
47
State Street Health Care Select Sector SPDR ETF
XLV
$41.7B
-172,300
Closed -$11M
LUMO
48
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
-20,278
Closed -$3.91M
MLNX
49
DELISTED
Mellanox Technologies, Ltd.
MLNX
-389,300
Closed -$17.5M
MDR
50
DELISTED
McDermott International
MDR
-1,518,333
Closed -$26.1M

Similar funds

Duquesne Family Office's Q4 2014 Portfolio in Review

As of Q4 2014, Duquesne Family Office held 52 positions worth $1.02B, up 25% from $815M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Duquesne Family Office deployed $115M of net new capital in Q4 2014, opening 16 new positions and adding to 14 existing holdings. Its largest new stake was Meta Platforms (Facebook): 430,000 shares worth $33.5M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 35% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Alcoa, an estimated $34.6M trimmed.

  • Duquesne Family Office's largest Q4 2014 buy was Meta Platforms (Facebook): 430,000 shares worth $33.5M.
  • Duquesne Family Office added most to Biogen in Q4 2014, an estimated $82.7M increase.
  • Duquesne Family Office's biggest Q4 2014 reduction was Alcoa, cutting an estimated $34.6M.
  • Duquesne Family Office fully exited Alphabet (Google) Class C in Q4 2014, selling an estimated $98.2M.
  • Duquesne Family Office's ten largest holdings make up 55% of its $1.02B portfolio in Q4 2014.
  • Duquesne Family Office opened 16 new positions and closed 17 in Q4 2014.
  • Duquesne Family Office's portfolio value rose 25% quarter-over-quarter to $1.02B.

Based on Duquesne Family Office's 13F filing for Q4 2014, filed 12 Feb 2015.